Patents by Inventor Steven Athwal

Steven Athwal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10233228
    Abstract: The application discloses albumin derivatives comprising or consisting of domain III and at least one further domain wherein the derivative or variant is not a naturally occurring albumin derivative or variant. The derivatives may be used in conjugates and fusion polypeptides.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: March 19, 2019
    Assignee: ALBUMEDIX LTD
    Inventors: Andrew Plumridge, Darrell Sleep, Inger Sandlie, Jan Terje Andersen, Jason Cameron, Leslie Evans, Steven Athwal, Elizabeth Allan, Esben Peter Friis
  • Publication number: 20130028930
    Abstract: The application discloses albumin derivatives comprising or consisting of domain III and at least one further domain wherein the derivative or variant is not a naturally occurring albumin derivative or variant. The derivatives may be used in conjugates and fusion polypeptides.
    Type: Application
    Filed: April 8, 2011
    Publication date: January 31, 2013
    Applicant: NOVOZYMES BIOPHARMA DK A/S
    Inventors: Andrew Plumridge, Darrell Sleep, Inger Sandlie, Jan Terje Andersen, Jason Cameron, Leslie Evans, Steven Athwal, Elizabeth Allan, Esben Peter Friis
  • Publication number: 20120059155
    Abstract: A method for producing antibodies in fungal host cells is provided where the produced antibodies has a low degree of glycosylation.
    Type: Application
    Filed: May 7, 2010
    Publication date: March 8, 2012
    Applicant: NOVOZYMES BIOPHARMA DK A/S
    Inventors: Leslie Robert Evans, Miranda Hughes, Joanna Hay, Darrell Sleep, David John Tooth, Neil Dodsworth, Malcolm John Saxton, Joanne Patricia Waters, Steven Athwal